Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans

References

• Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):407–421.
   PubMed Web of Science ®Google Scholar
• Courdi A, Brassart N, Herault J, et al. The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. Br J Radiol. 1994;67(800):800–804.
   PubMed Web of Science ®Google Scholar
• Wouters BG, Lam GK, Oelfke U, et al. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay. Radiat Res. 1996;146(2):159–170.
   PubMed Web of Science ®Google Scholar
• Coutrakon G, Cortese J, Ghebremedhin A, et al. Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons. Med Phys. 1997;24(9):1499–1506.
   PubMed Web of Science ®Google Scholar
• Cuaron JJ, Chang C, Lovelock M, et al. Exponential increase in relative biological effectiveness along distal edge of a proton bragg peak as measured by deoxyribonucleic acid double-strand breaks. Int J Radiat Oncol Biol Phys. 2016;95(1):62–69.
   PubMed Web of Science ®Google Scholar
• Howard ME, Beltran C, Anderson S, et al. Investigating dependencies of relative biological effectiveness for proton therapy in cancer cells. Int J Part Ther Winter. 2018;4(3):12–22.
   PubMedGoogle Scholar
• Paganetti H, Goitein M. Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak. Med Phys. 2000;27(5):1119–1126.
   PubMed Web of Science ®Google Scholar
• Kammerer E, Guevelou JL, Chaikh A, et al. Proton therapy for locally advanced breast cancer: a systematic review of the literature. Cancer Treat Rev. 2018;63:19–27.
   PubMed Web of Science ®Google Scholar
• Hug EB. Proton therapy for primary breast cancer. Breast Care. 2018;13(3):168–172.
   PubMed Web of Science ®Google Scholar
• MacDonald SM, Patel SA, Hickey S, et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(3):484–490.
   PubMed Web of Science ®Google Scholar
• Xu N, Ho MW, Li Z, et al. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease? Am J Clin Oncol. 2014;37(6):568–574.
   PubMed Web of Science ®Google Scholar
• Cuaron JJ, Chon B, Tsai H, et al. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2015;92(2):284–291.
   PubMed Web of Science ®Google Scholar
• Bradley JA, Dagan R, Ho MW, et al. Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared with photons. Int J Radiat Oncol Biol Phys. 2016;95(1):411–421.
   PubMed Web of Science ®Google Scholar
• Braunstein LZ, Cahlon O. Potential morbidity reduction with proton radiation therapy for breast cancer. Semin Radiat Oncol. 2018;28(2):138–149.
   PubMed Web of Science ®Google Scholar
• Indelicato DJ, Flampouri S, Rotondo RL, et al. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol. 2014;53(10):1298–1304.
   PubMed Web of Science ®Google Scholar
• Underwood T, Paganetti H. Variable proton relative biological effectiveness: how do we move forward? Int J Radiat Oncol Biol Phys. 2016;95(1):56–58.
   PubMed Web of Science ®Google Scholar
• Peeler CR, Mirkovic D, Titt U, et al. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016;121(3):395–401.
   PubMed Web of Science ®Google Scholar
• Underwood TSA, Grassberger C, Bass R, et al. Asymptomatic late-phase radiographic changes among chest-wall patients are associated with a proton RBE exceeding 1.1. Int J Radiat Oncol Biol Phys. 2018;101(4):809–819.
   PubMed Web of Science ®Google Scholar
• Mutter RW, Jethwa KR, Wan Chan Tseung HS, et al. Incorporation of biologic response variance modeling into the clinic: limiting risk of brachial plexopathy and other late effects of breast cancer proton beam therapy. Pract Radiat Oncol. 2020;10(2):e71–e81.
   PubMed Web of Science ®Google Scholar
• Wang CC, McNamara AL, Shin J, et al. End-of-range radiobiological effect on rib fractures in patients receiving proton therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2020;107(3):449–454.
   PubMed Web of Science ®Google Scholar
• Souris K, Lee JA, Sterpin E. Fast multipurpose Monte Carlo simulation for proton therapy using multi- and many-core CPU architectures. Med Phys. 2016;43(4):1700
   PubMed Web of Science ®Google Scholar
• Wagenaar D, Tran LT, Meijers A, et al. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system. Phys Med Biol. 2020;65(2):025006.
   PubMed Web of Science ®Google Scholar
• Liang X, Mailhot Vega RB, Li Z, et al. Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast cancer. Radiat Oncol. 2020;15(1):47.
   PubMed Web of Science ®Google Scholar
• Miura H, Inoue T, Shiomi H, et al. Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer. J Radiat Res. 2015;56(2):332–337.
   PubMed Web of Science ®Google Scholar
• Taremi M, Hope A, Lindsay P, et al. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy. Radiat Oncol. 2012;7(1):159.
   PubMed Web of Science ®Google Scholar
• Sorriaux J, Testa M, Paganetti H, et al. Experimental assessment of proton dose calculation accuracy in inhomogeneous media. Phys Med. 2017;38:10–15.
   PubMed Web of Science ®Google Scholar
• Huang S, Souris K, Li S, et al. Validation and application of a fast Monte Carlo algorithm for assessing the clinical impact of approximations in analytical dose calculations for pencil beam scanning proton therapy. Med Phys. 2018;45(12):5631–5642.
   PubMed Web of Science ®Google Scholar
• Deng W, Younkin JE, Souris K, et al. Technical note: integrating an open source Monte Carlo code "MCsquare" for clinical use in intensity-modulated proton therapy. Med Phys. 2020;47(6):2558–2574.
   Web of Science ®Google Scholar
• McMahon SJ, Paganetti H, Prise KM. LET-weighted doses effectively reduce biological variability in proton radiotherapy planning. Phys Med Biol. 2018;63(22):225009.
   PubMed Web of Science ®Google Scholar
• Carabe A, Moteabbed M, Depauw N, et al. Range uncertainty in proton therapy due to variable biological effectiveness. Phys Med Biol. 2012;57(5):1159–1172.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Blakely E, Carabe-Fernandez A, et al. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019;46(3):e53–e78.
   PubMed Web of Science ®Google Scholar
• Carabe-Fernandez A, Dale RG, Jones B. The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments. Int J Radiat Biol. 2007;83(1):27–39.
   PubMed Web of Science ®Google Scholar
• Elsasser T, Weyrather WK, Friedrich T, et al. Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. Int J Radiat Oncol Biol Phys. 2010;78(4):1177–1183.
   PubMed Web of Science ®Google Scholar
• Friedrich T, Scholz U, Elsasser T, et al. Calculation of the biological effects of ion beams based on the microscopic spatial damage distribution pattern. Int J Radiat Biol. 2012;88(1–2):103–107.
   PubMed Web of Science ®Google Scholar
• Wedenberg M, Lind BK, Hardemark B. A model for the relative biological effectiveness of protons: the tissue specific parameter alpha/beta of photons is a predictor for the sensitivity to LET changes. Acta Oncol. 2013;52(3):580–588.
   PubMed Web of Science ®Google Scholar
• McNamara AL, Schuemann J, Paganetti H. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data. Phys Med Biol. 2015;60(21):8399–8416.
   PubMed Web of Science ®Google Scholar
• Rørvik E, Thörnqvist S, Stokkevåg CH, et. al. A phenomenological biological dose model for proton therapy based on linear energy transfer spectra. Med Phys. 2017;44(6):2586–2594.
   PubMed Web of Science ®Google Scholar
• Grassberger C, Paganetti H. Elevated LET components in clinical proton beams. Phys Med Biol. 2011;56(20):6677–6691.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Botas P, Giantsoudi D, et al. Reoptimization of intensity modulated proton therapy plans based on linear energy transfer. Int J Radiat Oncol Biol Phys. 2016;96(5):1097–1106.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Paganetti H. Robust proton treatment planning: physical and biological optimization. Semin Radiat Oncol. 2018;28(2):88–96.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998.
   PubMed Web of Science ®Google Scholar
• Meric F, Buchholz TA, Mirza NQ, et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol. 2002;9(6):543–549.
   PubMed Web of Science ®Google Scholar
• Omarini C, Thanopoulou E, Johnston SR. Pneumonitis and pulmonary fibrosis associated with breast cancer treatments. Breast Cancer Res Treat. 2014;146(2):245–258.
   PubMed Web of Science ®Google Scholar
• Woodward WA, Amos RA. Proton radiation biology considerations for radiation oncologists. Int J Radiat Oncol Biol Phys. 2016;95(1):59–61.
   PubMed Web of Science ®Google Scholar
• Giovannini G, Böhlen T, Cabal G, et al. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios. Radiat Oncol. 2016;11:68.
   PubMed Web of Science ®Google Scholar
• Rørvik E, Fjaera LF, Dahle TJ, et al. Exploration and application of phenomenological RBE models for proton therapy. Phys Med Biol. 2018;63(18):185013.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Proton relative biological effectiveness – uncertainties and opportunities. Int J Part Ther. 2018;5(1):2–14.
   PubMedGoogle Scholar
• Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419–72.
   PubMed Web of Science ®Google Scholar
• Ödén J, Eriksson K, Toma-Dasu I. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation. Acta Oncol. 2017;56(6):769–778.
   PubMed Web of Science ®Google Scholar
• Ytre-Hauge KS, Fjaera LF, Rørvik E, et al. Inter-patient variations in relative biological effectiveness for cranio-spinal irradiation with protons. Sci Rep. 2020;10(1):6212.
   PubMed Web of Science ®Google Scholar
• Yepes P, Adair A, Frank SJ, et al. Fixed- versus variable-RBE computations for intensity modulated proton therapy. Adv Radiat Oncol. 2019;4(1):156–167.
   PubMedGoogle Scholar